Cargando…
A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
Recent studies suggested that RNA binding proteins (RBPs) were related to the tumorigenesis and progression of glioma. This study was conducted to identify prognostic RBPs of glioblastoma (GBM) and construct an RBP signature to predict the prognosis of GBM. Univariate Cox regression analysis was car...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191310/ https://www.ncbi.nlm.nih.gov/pubmed/35049227 http://dx.doi.org/10.1097/MD.0000000000028065 |
_version_ | 1784725984378880000 |
---|---|
author | Huang, Qian-Rong Li, Jian-Wen Pan, Xin-Bin |
author_facet | Huang, Qian-Rong Li, Jian-Wen Pan, Xin-Bin |
author_sort | Huang, Qian-Rong |
collection | PubMed |
description | Recent studies suggested that RNA binding proteins (RBPs) were related to the tumorigenesis and progression of glioma. This study was conducted to identify prognostic RBPs of glioblastoma (GBM) and construct an RBP signature to predict the prognosis of GBM. Univariate Cox regression analysis was carried out to identify the RBPs associated with overall survival of GBM in the The Cancer Genome Atlas (TCGA), GSE16011, and Repository for Molecular Brain Neoplasia data (Rembrandt) datasets, respectively. Overlapping RBPs from the TCGA, GSE16011, and Rembrandt datasets were selected. The biological role of prognostic RBPs was assessed by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein–protein interaction analyses. Least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis were used to construct an RBP-related risk signature. The prognostic value of RBP signature was measured by Kaplan–Meier method and time-dependent receiver operating characteristic curve. A nomogram based on independent prognostic factors was established to predict survival for GBM. The CGGA cohort was used as the validation cohort for external validation. This study identified 27 RBPs associated with the prognosis of GBM and constructed a 6-RPBs signature. Kaplan–Meier curves suggested that high-risk score was associated with a poor prognosis. Area under the curve of 1-, 3-, and 5-year overall survival was 0.618, 0.728, and 0.833 for TCGA cohort, 0.655, 0.909, and 0.911 for GSE16011 cohort, and 0.665, 0.792, and 0.781 for Rembrandt cohort, respectively. A nomogram with 4 parameters (age, chemotherapy, O(6)-methylguanine-DNA methyltransferase promoter status, and risk score) was constructed. The calibration curve showed that the nomogram prediction was in good agreement with the actual observation. The 6-RBPs signature could effectively predict the prognosis of GBM, and our findings supplemented the prognostic index of GBM to a certain extent. |
format | Online Article Text |
id | pubmed-9191310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-91913102022-06-13 A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma Huang, Qian-Rong Li, Jian-Wen Pan, Xin-Bin Medicine (Baltimore) 5700 Recent studies suggested that RNA binding proteins (RBPs) were related to the tumorigenesis and progression of glioma. This study was conducted to identify prognostic RBPs of glioblastoma (GBM) and construct an RBP signature to predict the prognosis of GBM. Univariate Cox regression analysis was carried out to identify the RBPs associated with overall survival of GBM in the The Cancer Genome Atlas (TCGA), GSE16011, and Repository for Molecular Brain Neoplasia data (Rembrandt) datasets, respectively. Overlapping RBPs from the TCGA, GSE16011, and Rembrandt datasets were selected. The biological role of prognostic RBPs was assessed by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein–protein interaction analyses. Least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis were used to construct an RBP-related risk signature. The prognostic value of RBP signature was measured by Kaplan–Meier method and time-dependent receiver operating characteristic curve. A nomogram based on independent prognostic factors was established to predict survival for GBM. The CGGA cohort was used as the validation cohort for external validation. This study identified 27 RBPs associated with the prognosis of GBM and constructed a 6-RPBs signature. Kaplan–Meier curves suggested that high-risk score was associated with a poor prognosis. Area under the curve of 1-, 3-, and 5-year overall survival was 0.618, 0.728, and 0.833 for TCGA cohort, 0.655, 0.909, and 0.911 for GSE16011 cohort, and 0.665, 0.792, and 0.781 for Rembrandt cohort, respectively. A nomogram with 4 parameters (age, chemotherapy, O(6)-methylguanine-DNA methyltransferase promoter status, and risk score) was constructed. The calibration curve showed that the nomogram prediction was in good agreement with the actual observation. The 6-RBPs signature could effectively predict the prognosis of GBM, and our findings supplemented the prognostic index of GBM to a certain extent. Lippincott Williams & Wilkins 2021-12-03 /pmc/articles/PMC9191310/ /pubmed/35049227 http://dx.doi.org/10.1097/MD.0000000000028065 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 5700 Huang, Qian-Rong Li, Jian-Wen Pan, Xin-Bin A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma |
title | A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma |
title_full | A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma |
title_fullStr | A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma |
title_full_unstemmed | A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma |
title_short | A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma |
title_sort | novel risk signature with 6 rna binding proteins for prognosis prediction in patients with glioblastoma |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191310/ https://www.ncbi.nlm.nih.gov/pubmed/35049227 http://dx.doi.org/10.1097/MD.0000000000028065 |
work_keys_str_mv | AT huangqianrong anovelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma AT lijianwen anovelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma AT panxinbin anovelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma AT huangqianrong novelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma AT lijianwen novelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma AT panxinbin novelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma |